Joshua Richardson - 08 Jun 2021 Form 4 Insider Report for Sierra Oncology, Inc. (SRRA)

Role
Director, 10%+ Owner
Signature
/s/ Joshua Richardson; By: Mary Christina Thomson, Attorney-In-Fact
Issuer symbol
SRRA
Transactions as of
08 Jun 2021
Transactions value $
$0
Form type
4
Filing time
09 Jun 2021, 10:19:25 UTC
Next filing
27 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRRA Stock Option (Right To Buy) Award $0 +6K $0.00 6K 08 Jun 2021 Common Stock 6K $18.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option fully vests and becomes exercisable on June 8, 2022, subject to the Reporting Person's provision of service to the Issuer as of the vesting date.